These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25260657)

  • 1. TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells.
    Liu X; Wang C; Gu Y; Zhang Z; Zheng G; He Z
    Mol Cell Biochem; 2015 Jan; 398(1-2):175-83. PubMed ID: 25260657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.
    Jia X; Zhang Z; Luo K; Zheng G; Lu M; Song Y; Liu H; Qiu H; He Z
    Sci Rep; 2017 Jun; 7(1):3744. PubMed ID: 28623290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).
    Peng B; Yi S; Gu Y; Zheng G; He Z
    Protein Expr Purif; 2012 Apr; 82(2):360-7. PubMed ID: 22365988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
    Gu Y; Fan S; Xiong Y; Peng B; Zheng G; Yu Y; Ouyang Y; He Z
    FEBS Lett; 2011 Mar; 585(6):881-7. PubMed ID: 21334329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma.
    Peng B; Gu Y; Xiong Y; Zheng G; He Z
    PLoS One; 2012; 7(12):e51413. PubMed ID: 23251525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCRP1 expression is associated with platinum sensitivity in human lung and ovarian cancer cells.
    Liu X; Feng M; Zheng G; Gu Y; Wang C; He Z
    Oncol Lett; 2017 Mar; 13(3):1398-1405. PubMed ID: 28454268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).
    Gu Y; Zhang Z; Yin J; Ye J; Song Y; Liu H; Xiong Y; Lu M; Zheng G; He Z
    J Exp Clin Cancer Res; 2017 Aug; 36(1):114. PubMed ID: 28859669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549].
    Li W; Liu X; Zhang G; Zhang L
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):298-302. PubMed ID: 28532536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X; Chen Y; Shen Y; Tantai J
    Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
    Zhou W; Wang J; Man WY; Zhang QW; Xu WG
    Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAM60A promotes cisplatin resistance in lung cancer cells by activating SKP2 expression.
    Hou Q; Jiang Z; Li Y; Wu H; Yu J; Jiang M
    Anticancer Drugs; 2020 Sep; 31(8):776-784. PubMed ID: 32796403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP.
    Li JJ; Ding Y; Li DD; Peng RQ; Feng GK; Zeng YX; Zhu XF; Zhang XS
    Cancer Biol Ther; 2009 Oct; 8(20):1914-21. PubMed ID: 20009541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
    He R; Liu H
    Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1.
    Ma Y; Li X; Cheng S; Wei W; Li Y
    Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Chen P; Li J; Jiang HG; Lan T; Chen YC
    Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.